Response to azathioprine treatment in autoimmune hepatitis is dependent on glutathione transferase genotypes
Open Access
- 24 January 2025
- journal article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 57 (4) , 885-892
Abstract
No abstract availableKeywords
Funding Information
- Futurum Academy of Health and Care
- Research Council of Southeast Sweden
This publication has 60 references indexed in Scilit:
- Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver DiseasesHepatology, 2019
- Comprehensive study of thiopurine methyltransferase genotype, phenotype, and genotype-phenotype discrepancies in SwedenBiochemical Pharmacology, 2019
- Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitisHepatology, 2012
- Clinicopathological features of severe and fulminant forms of autoimmune hepatitisJournal of Gastroenterology, 2010
- Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitisJournal of Gastroenterology, 2008
- Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel diseaseInflammatory Bowel Diseases, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: The role of glutathione and relevance to hepatic venoocclusive diseaseHepatology, 1996
- 6-Mercaptopurine: Cytotoxicity and biochemical pharmacology in human malignant T-lymphoblastsBiochemical Pharmacology, 1993
- The purine path to chemotherapyIn Vitro Cellular & Developmental Biology, 1989